← All Soleno Therapeutics INC filings

Soleno Therapeutics INC Form 4 insider transactions

NASDAQ
SLNO
Soleno Therapeutics INC
Form 4: Vivo Opportunity, LLC Sells Shares of Soleno Therapeutics Inc (SLNO)
Vivo Opportunity, LLC, a 10% owner of Soleno Therapeutics Inc, reports selling a significant number of common stock shares over two days.
NASDAQ
SLNO
Soleno Therapeutics INC
Form 4: Solen Therapeutics Executive Sells Shares to Cover Tax Obligations
Kristen Yen, a Senior Vice President at Soleno Therapeutics, sold shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
NASDAQ
SLNO
Soleno Therapeutics INC
Form 4: Solen Therapeutics CFO James H. Mackaness Sells Shares to Cover Tax Obligations
James H. Mackaness, CFO of Soleno Therapeutics Inc., sold shares of common stock on April 1, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.
NASDAQ
SLNO
Soleno Therapeutics INC
Form 4: Solen Therapeutics Executive Sells Shares to Cover Tax Obligations
Patricia C. Hirano, a Senior Vice President at Soleno Therapeutics, sold shares of common stock on April 1, 2024, to cover tax withholding obligations related to vesting restricted stock units.
NASDAQ
SLNO
Soleno Therapeutics INC
Form 4: Solen Therapeutics CEO Anish Bhatnagar Sells Shares to Cover Tax Obligations
Anish Bhatnagar, CEO of Soleno Therapeutics, sold shares of common stock on April 1, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.